Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer’s disease
Shan Ping Yu, Michael Qize Jiang, Seong S. Shim, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Targeting synapse function and loss for treatment of neurodegenerative diseases
Borislav Dejanovic, Morgan Sheng, Jesse E. Hanson
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 23-42
Closed Access | Times Cited: 40
DNA damage and its links to neuronal aging and degeneration
Ilse Delint‐Ramírez, Ram Madabhushi
Neuron (2025) Vol. 113, Iss. 1, pp. 7-28
Closed Access | Times Cited: 2
The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Brain Research (2024) Vol. 1829, pp. 148797-148797
Closed Access | Times Cited: 14
Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways
Jitendra Kumar Sinha, Anchal Trisal, Shampa Ghosh, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102211-102211
Closed Access | Times Cited: 13
Novel insight into the therapeutical potential of flavonoids from traditional Chinese medicine against cerebral ischemia/reperfusion injury
Jing Zhou, Feiyue Sun, Wenli Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 12
Glutamatergic Neurotransmission in Aging and Neurodegenerative Diseases: A Potential Target to Improve Cognitive Impairment in Aging
Selma Karime Castillo-Vázquez, Lourdes Massieu, Ruth Rincón-Heredia, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 6, pp. 103039-103039
Closed Access | Times Cited: 9
The role of N-methyl-D-aspartate glutamate receptors in Alzheimer’s disease: From pathophysiology to therapeutic approaches
Wenying Liu, Yan Li, Tan Zhao, et al.
Progress in Neurobiology (2023) Vol. 231, pp. 102534-102534
Closed Access | Times Cited: 16
Pathological Interplay between Inflammation and Mitochondria Aggravates Glutamate Toxicity
Annette Vaglio-Garro, Andrey V. Kozlov, Yuliya Smirnova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2276-2276
Open Access | Times Cited: 7
Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer’s and Parkinson’s Diseases: Insights into Current Medications
Deepa Gautam, Ulhas P. Naik, Meghna U. Naik, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1609-1609
Open Access | Times Cited: 14
Synaptic and extrasynaptic distribution of NMDA receptors in the cortex of Alzheimer's disease patients
Sergio Escamilla, Raquel Badillos, Joan X. Comella, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 5
NMDA receptor-mediated Ca2+ signaling: Impact on cell cycle regulation and the development of neurodegenerative diseases and cancer
Ana Laura González‐Cota, Daniel Martínez-Flores, Margarita Jacaranda Rosendo‐Pineda, et al.
Cell Calcium (2024) Vol. 119, pp. 102856-102856
Closed Access | Times Cited: 4
Two Signaling Modes Are Better than One: Flux-Independent Signaling by Ionotropic Glutamate Receptors Is Coming of Age
Valentina Brunetti, Teresa Soda, Roberto Berra‐Romani, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 880-880
Open Access | Times Cited: 4
Discovery of HZS60 as a Novel Brain Penetrant NMDAR/TRPM4 Interaction Interface Inhibitor with Improved Activity and Pharmacokinetic Properties for the Treatment of Cerebral Ischemia
Meiling Sun, Lin Wang, Qiaofeng Cao, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Potential edaravone/benzocyclopentenone derivatives alleviate cerebral ischemia reperfusion injury as neuroprotective agents
Qing Zeng, Huilan Li, Zunhua Yang, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108288-108288
Closed Access
Multi-functional Memantine Nitrate Attenuated Cognitive Impairment in Models of Vascular Dementia and Alzheimer’s Disease through Neuroprotection and Increased Cerebral Blood Flow
G.-J. Chen, Kexin Zhang, Minghua Sun, et al.
Neuropharmacology (2025), pp. 110410-110410
Closed Access
Natural aminosterols inhibit NMDA receptors with low nanomolar potency
Giulia Fani, Elisabetta Coppi, Silvia Errico, et al.
FEBS Journal (2025)
Open Access
Changes in the Properties of Ethanol-Sensitive Molecular Targets During Maturation and Aging
Luis G. Aguayo, Lorena Armijo‐Weingart, Loreto San Martín, et al.
Advances in experimental medicine and biology (2025), pp. 299-316
Closed Access
Design of Anti-depressant Phosphodiester Amino Acidic Keap1-Nrf2 Protein-Protein Interaction Inhibitors
Yi Sun, Jue Wang, Wanyu Ding, et al.
Redox Biology (2025), pp. 103620-103620
Open Access
An emerging role of SNAREs in ischemic stroke: From pre-to post-diseases
Yaxin Liu, Jung Hwa Hong, Guozuo Wang, et al.
Biochemical Pharmacology (2025), pp. 116907-116907
Open Access
Rearranged Homoadamantane-Type Polycyclic Polyprenylated Acylphloroglucinols from Hypericum pseudohenryi
Nana Jiang, Yan-Song Ye, Xia Liu, et al.
Organic Letters (2023) Vol. 25, Iss. 50, pp. 8965-8969
Closed Access | Times Cited: 11
Structural and functional remodeling of neural networks in β-amyloid driven hippocampal hyperactivity
Jinquan Li, Yanjun Liu, Chuhui Yin, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102468-102468
Closed Access | Times Cited: 3
A More Holistic Perspective of Alzheimer's Disease: Roles of Gut Microbiome, Adipocytes, HPA Axis, Melatonergic Pathway and Astrocyte Mitochondria in the Emergence of Autoimmunity
George Anderson
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 12, pp. 355-355
Open Access | Times Cited: 7
Sorl1 knockout inhibits expression of brain-derived neurotrophic factor: involvement in the development of late-onset Alzheimer's disease.
Mingri Zhao, Xun Chen, Jiangfeng Liu, et al.
PubMed (2024) Vol. 19, Iss. 7, pp. 1602-1607
Closed Access | Times Cited: 2
Combination strategy employing BACE1 inhibitor and memantine to boost cognitive benefits in Alzheimer’s disease therapy
Abu Md Mamun Tarif, Hasi Huhe, Masuo Ohno
Psychopharmacology (2024) Vol. 241, Iss. 5, pp. 975-986
Closed Access | Times Cited: 2
On the functions of astrocyte-mediated neuronal slow inward currents
Balázs Pál
Neural Regeneration Research (2024) Vol. 19, Iss. 12, pp. 2602-2612
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top